Powered by
DETROIT–Henry Ford Health will be spearheading a multi-center, first-of-its-kind national clinical trial dubbed the “CORRAL-AF IDE” study for an innovative left atrial appendage occlusion device known as the LAmbre Plus …
GRAND RAPIDS–Burke Porter Group announced the acquisition of Quantum 3, a global designer of workflow process optimization in the manufacturing and life sciences industries. Quantum 3 offers modular flexible aluminum …
ANN ARBOR–Endra Life Sciences Inc. (Nasdaq: NDRA), developers of Thermo Acoustic Enhanced UltraSound (TAEUS) medical diagnostic technology, announced that it will be effecting a reverse stock split of its outstanding …
ROCHESTER HILLS—A Rochester Hills doctor is monitoring the recovery and activity level of his knee replacement patients using smartwatch technology. Jeffrey DeClaire, M.D., founder of the Michigan Knee Institute, uses …
ANN ARBOR—ENDRA Life Sciences Inc., developers of thermo acoustic enhanced ultrasound technology for medical diagnosis, announced it had received two new United States Patents—No. 11,456,518, for “Method for Manufacturing a …
GRAND RAPIDS–San Diego, Calif.-based D&K Engineering has been acquired by Grand Rapids-based Burke Porter Group, officials of the two companies announced. Terms were not disclosed. Founded in 1999, D&K is …
ANN ARBOR–NovoDynamics Inc., the artificial intelligence products and services provider for the dental industry, has been granted United States Patent No. 11,464,466 for a new screening technology for evaluating X-rays …
KALAMAZOO–The Kalamazoo-based medical device developer Stryker Corp.(NYSE:SYK) has announced the launch of its Q Guidance System for spine applications. The system combines new optical tracking options provided by a redesigned …
DETROIT–The Barbara Ann Karmanos Cancer Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, has become the first cancer center to receive the SoftVue 3D Whole Breast Ultrasound Tomography System following …
ANN ARBOR–HistoSonics Inc., the developer and manufacturer of a completely non-invasive platform and proprietary sonic beam therapy, announced the publication of results from their prospective Phase I clinical trial, conducted …